Anuh Pharma Ltd is currently trading at Rs. 164, down by Rs. 11.9 or 6.77% from its previous closing of Rs. 175.9 on the BSE. Anuh Pharma Ltd has informed BSE that in view of the EDQM suspension, the WHO PQ authorities have suspended Pyrazinamide and Sulfadoxine from the WHO list of prequalified API's until the WHO led inspection.
The scrip opened at Rs. 176.3 and has touched a high and low of Rs. 179.7 and Rs. 162 respectively. So far 35246(NSE+BSE) shares were traded on the counter. The current market cap of the company is Rs. 440.74 crore.
The BSE group 'XC' stock of face value Rs. 5 has touched a 52 week high of Rs. 414.75 on 12-Aug-2015 and a 52 week low of Rs. 174.1 on 20-Apr-2016. Last one week high and low of the scrip stood at Rs. 179.5 and Rs. 174.1 respectively.
The promoters holding in the company stood at 70.98 % while Institutions and Non-Institutions held 0 % and 29.02 % respectively.
The stock is currently trading below its 200 DMA.